MacKay E N, Sellers A H
Can Med Assoc J. 1967 Jun 24;96(25):1626-35.
In Ontario, leukemia causes about 4% of all cancer deaths, ranging from nearly 50% at under 5 years of age to 1-3% at age 50 and over. Age-specific death rates are highest among older people; at all ages, male deaths exceed female deaths. Only about 20% of all leukemia patients in Ontario are registered at Ontario Cancer Clinics; the proportion changed sharply with the advent of chemotherapy. For 1258 patients registered in 1938-1963, the crude one-year survival rate was 50%, ranging from 9% for acute leukemia to about 60% for non-acute lymphatic and myeloid leukemia. The long-term outlook was much better for non-acute lymphatic leukemia than for non-acute myeloid leukemia. For acute leukemia, the treatment of choice was chemotherapy; for non-acute lymphatic leukemia, radiotherapy was used, followed, if required, by chemotherapy or further radiotherapy. For non-acute myeloid leukemia, the advantage of chemotherapy over radiotherapy was not established.
在安大略省,白血病导致的癌症死亡约占所有癌症死亡的4%,在5岁以下儿童中这一比例接近50%,而在50岁及以上人群中为1%至3%。特定年龄死亡率在老年人中最高;在所有年龄段,男性死亡人数超过女性死亡人数。安大略省所有白血病患者中只有约20%在安大略癌症诊所登记;随着化疗的出现,这一比例发生了急剧变化。对于1938年至1963年登记的1258名患者,一年粗生存率为50%,急性白血病为9%,非急性淋巴细胞和髓细胞白血病约为60%。非急性淋巴细胞白血病的长期预后比非急性髓细胞白血病好得多。对于急性白血病,首选治疗方法是化疗;对于非急性淋巴细胞白血病,采用放射治疗,必要时随后进行化疗或进一步放射治疗。对于非急性髓细胞白血病,化疗相对于放射治疗的优势尚未确立。